Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine
- PMID: 8981969
- PMCID: PMC1712555
Item in Clipboard
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine
Am J Hum Genet.
1997 Jan.
No abstract available
Similar articles
-
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.J Clin Endocrinol Metab. 1998 Feb;83(2):487-91. doi: 10.1210/jcem.83.2.4529. J Clin Endocrinol Metab. 1998. PMID: 9467562
-
Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.Hum Mol Genet. 1994 Aug;3(8):1259-62. doi: 10.1093/hmg/3.8.1259. Hum Mol Genet. 1994. PMID: 7987299
-
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review.
-
Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.Am J Med. 1996 Dec;101(6):635-41. doi: 10.1016/s0002-9343(96)00330-0. Am J Med. 1996. PMID: 9003111
-
[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.
Cited by
-
Molecular diagnosis and comprehensive treatment of multiple endocrine neoplasia type 2 in Southeastern Chinese.Hered Cancer Clin Pract. 2015 Jan 20;13(1):5. doi: 10.1186/s13053-015-0026-1. eCollection 2015. Hered Cancer Clin Pract. 2015. PMID: 25628771 Free PMC article.
-
Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).Langenbecks Arch Surg. 2014 Feb;399(2):185-97. doi: 10.1007/s00423-013-1139-5. Epub 2013 Dec 3. Langenbecks Arch Surg. 2014. PMID: 24297502
-
Multiple endocrine neoplasia type 2 and the practice of molecular medicine.Rev Endocr Metab Disord. 2000 Nov;1(4):283-90. doi: 10.1023/a:1026514301172. Rev Endocr Metab Disord. 2000. PMID: 11706742 Review. No abstract available.
-
RET proto-oncogene mutations in thyroid carcinomas: clinical relevance.J Endocrinol Invest. 2000 May;23(5):328-38. doi: 10.1007/BF03343732. J Endocrinol Invest. 2000. PMID: 10882153 Review.
-
Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.J Clin Res Pediatr Endocrinol. 2016 Mar 5;8(1):13-20. doi: 10.4274/jcrpe.2219. Epub 2015 Dec 18. J Clin Res Pediatr Endocrinol. 2016. PMID: 26758973 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical